Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Protagonist Therapeutics Inc (NASDAQ: PTGX) was $44.79 for the day, down -0.29% from the previous closing price of $44.92. In other words, the price has decreased by -$0.29 from its previous closing price. On the day, 0.56 million shares were traded. PTGX stock price reached its highest trading level at $45.15 during the session, while it also had its lowest trading level at $43.96.
Ratios:
Our analysis of PTGX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.43. For the most recent quarter (mrq), Quick Ratio is recorded 13.73 and its Current Ratio is at 13.73. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 09, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On October 30, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $32.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 11 ’24 when Ali Asif bought 14,203 shares for $44.49 per share.
WILLIAM D WADDILL bought 8,000 shares of PTGX for $360,000 on Sep 10 ’24. On Jul 24 ’24, another insider, Waddill William D., who serves as the Director of the company, sold 8,000 shares for $40.00 each. As a result, the insider received 320,000 and left with 12,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2645996288 and an Enterprise Value of 2085310336. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.27 while its Price-to-Book (P/B) ratio in mrq is 4.86. Its current Enterprise Value per Revenue stands at 6.535 whereas that against EBITDA is 13.611.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $45.07, while it has fallen to a 52-week low of $13.72. The 50-Day Moving Average of the stock is 15.09%, while the 200-Day Moving Average is calculated to be 49.90%.
Shares Statistics:
PTGX traded an average of 948.98K shares per day over the past three months and 554840 shares per day over the past ten days. A total of 57.71M shares are outstanding, with a floating share count of 55.65M. Insiders hold about 5.53% of the company’s shares, while institutions hold 96.72% stake in the company. Shares short for PTGX as of 1723680000 were 3100480 with a Short Ratio of 3.27, compared to 1721001600 on 3262628. Therefore, it implies a Short% of Shares Outstanding of 3100480 and a Short% of Float of 5.3400002.
